UK Growth Companies With High Insider Ownership In July 2024

The United Kingdom market has experienced relatively stable performance recently, showing a modest annual increase of 4.9% with expectations for earnings to grow by 13% per annum. In this context, growth companies with high insider ownership can be particularly compelling, as significant stakeholder investment often aligns with strong company performance and governance.

Top 10 Growth Companies With High Insider Ownership In The United Kingdom

Name	Insider Ownership	Earnings Growth
Plant Health Care (AIM:PHC)	34.1%	121.3%
Petrofac (LSE:PFC)	16.6%	124%
Gulf Keystone Petroleum (LSE:GKP)	12.1%	74.6%
Integrated Diagnostics Holdings (LSE:IDHC)	26.7%	23.5%
Foresight Group Holdings (LSE:FSG)	31.9%	27.9%
Helios Underwriting (AIM:HUW)	23.1%	14.7%
Velocity Composites (AIM:VEL)	27.6%	173.3%
B90 Holdings (AIM:B90)	24.4%	142.7%
Judges Scientific (AIM:JDG)	11.5%	25.3%
Hochschild Mining (LSE:HOC)	38.4%	42.6%

Click here to see the full list of 61 stocks from our Fast Growing UK Companies With High Insider Ownership screener.

Let's dive into some prime choices out of from the screener.

Craneware (AIM:CRW)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Craneware plc develops, licenses, and supports computer software for the healthcare industry primarily in the United States, with a market capitalization of approximately £828.40 million.

Operations: The company generates its revenue primarily from its healthcare software segment, which brought in $180.56 million.

Insider Ownership: 17%

Earnings Growth Forecast: 29.4% p.a.

Craneware, a UK-based company, is poised for robust growth with its earnings expected to increase by 29.39% annually. Despite a forecasted low return on equity of 11.2% in three years, the firm's revenue growth at 6.7% per year outpaces the UK market prediction of 3.5%. Recent strategic collaboration with Microsoft enhances Craneware's offerings on Azure Marketplace, leveraging AI and cloud technologies to broaden market reach and drive innovation in healthcare analytics and operations management.

• Click here and access our complete growth analysis report to understand the dynamics of Craneware.
• Our comprehensive valuation report raises the possibility that Craneware is priced higher than what may be justified by its financials.

Judges Scientific (AIM:JDG)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Judges Scientific plc is a company that designs, manufactures, and sells scientific instruments, with a market capitalization of approximately £747.15 million.

Operations: The company generates revenue through two primary segments: Vacuum, which brings in £63.60 million, and Materials Sciences, contributing £72.50 million.

Insider Ownership: 11.5%

Earnings Growth Forecast: 25.3% p.a.

Judges Scientific, a UK entity, exhibits mixed financial health with a high level of debt and profit margins decreasing from 11% to 7% over the past year. However, it shows promising growth prospects with earnings expected to rise by 25.32% annually, outpacing the UK market's forecast of 12.6%. Recent AGM decisions reflect strategic adjustments in company bylaws and an approved dividend increase, signaling potential stability and commitment to shareholder returns despite slower revenue growth at 4.8% per year.

• Dive into the specifics of Judges Scientific here with our thorough growth forecast report.
• Upon reviewing our latest valuation report, Judges Scientific's share price might be too optimistic.

Kainos Group (LSE:KNOS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Kainos Group plc is a provider of digital technology services operating in the United Kingdom, Ireland, North America, Central Europe, and other international markets, with a market capitalization of approximately £1.35 billion.

Operations: The company generates revenue through three primary segments: Digital Services (£213.10 million), Workday Products (£57.25 million), and Workday Services (£112.04 million).

Insider Ownership: 23.3%

Earnings Growth Forecast: 13.1% p.a.

Kainos Group, a UK-based company, demonstrates robust growth with a 13.1% forecast in annual earnings growth, slightly above the UK market average. Despite an unstable dividend track record, the firm's revenue is expected to increase by 8.8% annually, outstripping the general market's 3.5%. Recent strategic alliances, like the partnership with Pulsora to enhance corporate sustainability through ESG technology solutions, underscore Kainos' commitment to integrating cutting-edge digital innovations in its operations. However, there has been no substantial insider buying in the past three months.

• Get an in-depth perspective on Kainos Group's performance by reading our analyst estimates report here.
• In light of our recent valuation report, it seems possible that Kainos Group is trading behind its estimated value.

Summing It All Up

• Unlock our comprehensive list of 61 Fast Growing UK Companies With High Insider Ownership by clicking here.
• Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com